is the compounded semaglutide safe Troubling Findings in Study of GLP-1 Compounders Compounded Semaglutide: How to Better

For patients who have been priced out of GLP-1 treatment, the arrival of a $149 per month oral option from a major manufacturer is the most significant access development since the LillyDirect launch

Resistance exercise can help protect muscle mass and improve body shape as weight comes down

Retatrutide is a once-weekly injectable triple agonist (GLP-1, GIP, and glucagon receptor) developed by Eli Lilly for obesity and type 2 diabetes

Lykkegaard, K

Real-World Results vs Clinical Trials Clinical trials occur under controlled conditions

Discussion The presented analyses highlight the complexities of evaluating potential disease-modifying therapies in early-stage PD